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Head and neck sarcomas are relatively rare tumors, with angiosarcomas representing a small subset. Angiosarcoma is a malignant
endothelial neoplasm characterized by atypical, multilayered, or solid endothelial proliferation with vasoformative architecture.
The global incidence of irradiation-associated sarcoma is estimated as between 0.03% and 0.08%. Here we reported the case of
an elderly woman previously treated with radiation more than 20 years ago for an unknown primary of head and neck. This
interesting case presented as a diagnostic challenge, and multiple biopsies were required to eventually establish the diagnosis of
laryngeal angiosarcoma. We additionally have conﬁrmation from our prior radiation records that the patient did, in fact, receive
a substantial dose of radiation to the site previously. To our knowledge, this case represents the ﬁrst report of a documented
radiation-induced multifocal laryngeal angiosarcoma.
1.Introduction
Head and neck sarcomas are relatively rare tumors, with
angiosarcomas representing a small subset. Angiosarco-
mas have a higher propensity to aﬀect the elderly and
prior studies exist correlating them to radiation exposure.
Angiosarcomas tend to originate either from blood vessels or
lymphatic vessels. Most head and neck angiosarcomas tend
to be observed in the face or scalp. In nonvisible areas of
the body, the tumor generally presents as a palpable mass
or with symptoms speciﬁc to the site. After treatment, the
tumortendstorecurlocally;however,distantmetastasesmay
also occur. The best determinant of overall survival is the
ability to completely resect the tumor with a negative and
wide margin. While surgery is the main form of treatment,
theoverallsurvivalforpatientswithangiosarcomaislowand
opportunity of a wide resection margin is rare in the head
and neck region. For these reasons, patients with a high-
grade lesion and/or positive or close margins may beneﬁt
from adjuvant chemoradiation therapy.
We report the case of an elderly woman previously
treatedwithradiationmorethat20yearsagoforanunknown
primary of head and neck who now presented with a fun-
gating supraglottic mass. This interesting case presented as a
diagnostic challenge, and multiple biopsies were required to
eventually establish the diagnosis of laryngeal angiosarcoma.
2.CaseReport
An 83-year-old female was directed to the emergency
department by her primary care physician three weeks after
falling on her left ﬂank for a CT of her abdomen. This
CT showed concern for bile duct dilatation, but as she
was asymptomatic, she was discharged home with followup.2 Case Reports in Otolaryngology
Several days later an endoscopic retrograde cholangiopan-
creatography (ERCP) was performed, and a large hypopha-
ryngeal mass was incidentally noted. A biopsy was taken at
the time of her GI procedure. The patient was subsequently
admitted, and ENT was consulted the following day. Her
past medical history includes hypertension, congestive heart
failure, stroke, and history of cervical metastasis from
unknown primary that was treated with radiation therapy
21years ago.
This patient was originally diagnosed with a T0N1M0
cancer of unknown primary in 1987. A primary site was
not identiﬁed on CT of the head, neck, chest, abdomen, and
pelvisaswellasquadrupleendoscopy.Fine-needleaspiration
of the neck mass was positive for a poorly diﬀerentiated
carcinoma. The lesion was 1–1.5 cm in size in the right
jugular digastric region just below the angle of the mandible.
Shereceiveddeﬁnitiveradiationtherapytotheheadandneck
region at Gershenson Radiation Oncology Center, Detroit,
MI, from February 11th, 1987 to May 5th, 1987. She received
treatment to the neck node and potential sites of primary
via left and right lateral opposing ports to 3600rads by
means of Cobalt 60. After this dose, oﬀ-cord treatment was
delivered to the left and right anterior neck to an additional
1440rads. Finally, the site of cervical adenopathy was given
an additional boost of 900rads with 10MV electrons. The
lateral supraclavicular ﬁeld and posterior neck were also
treated. On review of the treatment portals and prescribed
therapy, the patient received a cumulative dose of 5940rads
to the anterior neck 20years prior. The anterior neck
irradiated included epiglottis and larynx.
On further questioning, patient admitted to one-month
history of dysphagia to solids and liquids. She reported a
globus-type sensation as well as discomfort when eating.
She also had intermittent hot potato voice and coughing
episodes. She has had a twenty-pound weight loss and was
more easily fatigued. However, she denied any fevers, night
sweats,shortnessofbreath,orotalgia.Thepatientisaformer
heavy tobacco user, about a pack a day to a third of a
pack a day. She denied any alcohol or drug use. On phys-
ical examination, a large and fungating epiglottic mass
extending into thebaseof thetongue wasnoted onﬁberoptic
nasopharyngoscopy. Neck examination revealed no obvious
lymphadenopathy.
CT scan of the neck and thorax with IV contrast per-
formed the same day demonstrated a heterogeneous enhanc-
ing epiglottic mass which involves the preepiglottic space
and extends inferiorly along the mucosal pharyngeal space
more on the right involving the laryngeal surface of the
aryepiglottic folds. This mass measures 2 × 1.8 × 1.6cm.
The mass extends to involve the false cords and possibly
the superior aspect of the right true vocal cord. There is
no cartilage invasion, retrocricoid invasion, or subglottic
extension. No signiﬁcant lymphadenopathy.
The original biopsy at the time of ERCP returned
necrotic debris with focal squamous features and cellular
atypia. Numerous clusters of bacterial and fungal ele-
ments were consistent with candida. The patient was then
taken back to the operating room for triple endoscopy,
tracheostomy, and biopsies. Direct laryngoscopy revealed
a friable, exophytic mass involving the base of tongue,
vallecula, and the oral surface of the epiglottis as well as the
laryngeal surface of the epiglottis down to the aryepiglottic
fold but does not involve the false vocal cord, arytenoid, pir-
iform sinus, or the postcricoid space. The mass was biopsied.
Direct bronchoscopy was negative. Direct esophagoscopy
revealed a duodenal mass which was biopsied. A PEG tube
wasplaced.Thepathologyreturnedpredominantlyﬁbrinop-
urulent exudates and necrotic debris with bacterial and
fungal organisms. Because of the negative biopsy, the patient
was once again taken to the operating room for biopsy. This
was biopsied several times and sent oﬀ for frozen section.
Frozen section was negative. We then sent oﬀ for another
set of biopsy specimens. Again this was negative. We sent
a third set of biopsy specimens, and this was deferred for
permanent. Pathology returned benign squamous mucosa
with marked subepithelial inﬂammation, ﬂorid granulation
tissuewithprominentendothelialproliferationandextensive
necrosis. Sections show extensive necrosis with prominent
exuberant granulation tissue with spindle-cell proliferation
and a chronic inﬂammatory inﬁltrate. The spindle cells do
not show much cytologic atypia, and no mitotic ﬁgures were
noted. Some of the spindle cells appear to form vascular
channels. The diﬀerential diagnosis included ﬂorid granula-
tion tissue formation, a poorly diﬀerentiated spindle-celled
carcinoma or a spindle-cell sarcoma. Immunohistochemical
stains were performed and included actin (smooth muscle
marker), CD31 (endothelial marker), P63, CAM5.2, and
AE1/AE3 epithelial markers. Sections showed the spindle
cells to stain strongly with the CD31, while the other stains
were essentially negative in the spindle cell area. This is con-
sistent with a ﬂorid endothelial proliferation or granulation
tissue formation. No unequivocal malignancy is seen in this
specimen.
After three negative and inconclusive biopsies, patient’s
case was discussed in the Multidisciplinary Head and Neck
Tumor Board, and a recommendation for a larger and
moreaggressivebiopsywasrecommended.Infectiousdisease
has also been consulted regarding this patient, and they
requested tissue for cultures. After extensive discussion with
the patient and her family, patient was taken back to OR
for extensive debulking of the epiglottic mass. The ﬁnal
pathologic diagnosis was angiosarcoma. The biopsy shows
a highly cellular neoplasm with necrosis. Tumor cells are
positiveforCD31,CD34,andnegativeforFactorVIII,cytok-
eratin AE1/AE3 and CK903. The morphology and immuno-
proﬁle are diagnostic of epithelioid angiosarcoma. Outside
consultation from the University of Michigan ultimately
agreedwiththeabovediagnosis. Thepatientthenunderwent
a total laryngectomy and cricopharyngeal myotomy with
tracheoesophageal puncture. During the surgery, 2 primary
foci involving the epiglottis and base of the tongue were
noted(Figure 1).Theﬁnalpathologyconﬁrmedthepresence
of multifocality with a 2.2cm lesion in the epiglottis and
a 1.5cm lesion in the base of tongue. All margins were
negative, and the pathology showed high-grade epitheliod
angiosarcoma of the epiglottis (Figures 2 and 3). Unfortu-
nately, the patient developed several complications, includ-
ing ﬁstula, syncope, seizure, and pneumonia, following theCase Reports in Otolaryngology 3
Figure 1
Figure 2
surgery, and discussion of adjuvant chemoradiation therapy
was delayed. Patient was doing well until approximately
10months after the surgery when she was noted to have a
purplish lesion in the right tonsil area. CT scan of neck and
chest was negative. Examination under anesthesia revealed
2foci of lesion, one in the right tonsil and one in the left
pharynx. Biopsy showed angiosarcoma. Patient was taken
back to the OR for right radical tonsillectomy and L partial
pharyngectomy. Patient did well postoperatively and was
started on adjuvant chemotherapy consisting of taxotere.
Approximately 6months after the last surgery, patient was
again noted to have purplish lesion in the left base of tongue
region. She was experiencing signiﬁcant side eﬀects from the
chemotherapy, and family decided to put her in hospice. She
died 2months later.
3. Discussion
Primary laryngeal sarcomas have been determined to com-
prise only 0.32%, 0.55%, and 0.87% of all laryngeal malig-
nancies based on previous studies [2]. Of these, chon-
drosarcoma is the most common, followed by ﬁbrosarcoma.
Figure 3
Angiosarcoma constitutes a smaller subset of the malignant
sarcomas. Angiosarcoma of the larynx is a rare malignant
tumor, accounting for less than 1% of all malignant tumors
ofthelarynx[5].Ofthelaryngealangiosarcomasanalyzedby
Miuraet al. most arose from the supraglottis (64.3%), often
with epiglottic invasion, followed by the glottis (28.6%), and
subglottis (7.1%) [2, 4].
Angiosarcoma is a malignant endothelial neoplasm
characterized by atypical, multilayered, or solid endothelial
proliferation with vasoformative architecture [2]. The global
incidence of irradiation-associated sarcoma is estimated as
between 0.03% and 0.08% [6]. Eleven cases of angiosarcoma
of the head and neck were reviewed the mean age was
determined to be 64years; surgery was the primary method
of treatment; 2-year survival rate was 50%; 5-year survival
rate was 22%. Regional metastases were seen in 18%. In
this study, the tumors were found to be poorly, circum-
scribed and tended to spread horizontally within the dermis
for considerable distances [7]. Another study of primary
laryngeal sarcomas found the mean age to be 62.2years,
a predominance for male patients: 9:5 with the main
symptoms being hoarseness followed by hemoptysis. The
symptoms were present for a mean of 6.3months on diagno-
sis [2]. Angiosarcomas account for only 1% of all soft tissue
sarcomas, 60% of which are cutaneous. The occurrence of
an angiosarcoma in the oral cavity is unusual. About 4% of
angiosarcomashavebeenfoundintheparanasalsinuses,oral
cavity, or pharynx [8]. Although angiosarcoma can occur in
anyorgan,ittypicallypresents:(1)inthefaceorscalpamong
elderly,(2)withchroniclymphedema,(3)afterradiotherapy,
or (4) as a hepatic primary [9]. The least frequent is one
which develops following previous radiation therapy [8].
Some cases are believed to be radiation-induced. Other
possible causative factors include: trauma, lymphoedema,
foreign bodies, vinyl chloride and, arsenic [2].
Only 13case reports of primary laryngeal angiosarcoma
have been reported in the English literature to date Tables
1 and 2. Only 2 of those documented as possibly radiation-
induced [2]. Also, only one of the laryngeal angiosarcomas
is speciﬁcally determined to be of origin in the epiglottis;
however, in this case, the patient had not received prior
radiation [10]. In the case report not only we present our
patient deﬁnitively that is diagnosed with an angiosarcoma
of the epiglottis, but also we have conﬁrmation from our4 Case Reports in Otolaryngology
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Table 2: Radiation-associated angiosarcoma of the larynx.
Author Angiosarcoma site Initial primary RT Latency
Laskin et al. 1988 [3, #212] Larynx Larynx SCCA 68Gy 3 years
Loos et al. 2001 [4, #11] Supraglottis Breast Ca, cervical lymph nodes 66Gy 7 months
Loos et al. 2001 [4, #11] Supraglottis Unknown primary Unknown dose 10 years
Table 3: Criteria for radiation-induced malignancy.
(1) The site of origin must be within the ﬁeld of previous
radiation
(2) The patient should have received a signiﬁcant amount of
radiation therapy (greater than 2,500rads)
(3) An interval of at least 3–5 years must elapse between the
time of irradiation and the development of the sarcoma
(4) The second primary cancer needs to be histologically
diﬀerent from the primary neoplasm
prior radiation records that the patient did, in fact, receive
a substantial dose of radiation to the site previously. In order
to attribute to prior radiation treatment as the causative
factor the following classiﬁcation has to be met: (i) the site
of origin must be within the ﬁeld of previous radiation;
(ii) the patient should have received a signiﬁcant amount of
radiationtherapy(greaterthan2,500rads);(iii)anintervalof
at least 3–5 years must elapse between the time of irradiation
andthedevelopmentofthesarcoma;(iv)thesecondprimary
cancer need is histologically diﬀerent from the primary
neoplasm (Table 3)[ 2, 6]. In the case of our patient: the
epiglottis was included in the site of the prior radiation
ﬁeld encompassing the boost, the patient received 5,940rads,
an interval of 20years had elapsed between her last cancer
and the development of the angiosarcoma, and the primary
cancer 20years ago had been histologically identiﬁed as
squamous cell carcinoma.
Radiation therapy has been well documented as a
causative factor in the formation of basal-cell carcinoma
and squamous cell carcinoma, but only rarely angiosarcoma
[8]. It is viewed as a rare, but possible late complication
of radiotherapy in patients who have received a signiﬁcant
amount of irradiation, usually between 25 and 60Gy. There
is usually a latency period of at least 10years or longer.
In a review of postradiation soft-tissue sarcomas (53cases,
one an angiosarcoma), the tumors were correlated with the
characteristics of the radiation. No diﬀerence was noted
between the patients treated with megavoltage radiation and
with orthovoltage radiation in the type of sarcoma, location,
or survival. The orthovoltage group had received a lower
mean radiation dose (4446rads), but the megavoltage group
was associated with a shorter latency period [3].
Immunohistochemical and histologic features, are
required for identiﬁcation. Histologically, in angiosarcomas
the most common type is epitheliod angiosarcoma [11].
Frequently, the tumors will have anastomosing vascular
channels lined by remarkably atypical mitotic ﬁgures, and
hemorrhage [4]. Immunohistochemical staining with factor
VIII-related antigen of a plasma glycoprotein synthesized
by endothelial cells [8]. Angiosarcoma can be conﬁrmed
immunohistologically by using endothelial markers such as
factor VIII-related antigen, UEA I, CD31, and CD 34.
However, these markers are not labeled for all angiosarcomas
because endothelial diﬀerentiation markers are expressed
diﬀerentlyfromcasetocaseandevenwithinthesametumor.
Of the markers, factor VIII-related antigen immunostaining
was generally the most focal. Immunostaining of cytokeratin
and vimentin, at least, is mandatory to ascertain the
diagnosis if secondary sarcoma is suspected [2]. In the
cases studied by Meis-Kindblom and Kindblom, all 42cases
stained at least focally for factor VIII-related antigen, and
nearly all stained strongly for vimentin, which accentuated
the endothelial cells and vessel lumen formation. CD34
antigen was detected in 74% of cases, BNH9 in 72%, and
cytokeratins in 35% [11].
The overall prognosis of angiosarcoma is poor. They
spread by both the lymph system and via blood vessels [12].
Regarding tumor size, the larger the tumor, the worse the
prognosis.Pedunculatedandsmall-sizetumorsshowabetter
outcome. Poor prognosis is also related to an older patient
age, retroperitoneal location, and high MIB-1 labeling index
≥10% of tumor cell population [2, 11]. Lydiatt et al. treated
18patients from 1978 to 1992 with 16scalp angiosarcomas
and 2 in the oropharynx. Primary surgery was utilized in
9 of the patients, 1 received adjuvant chemotherapy, and 2
received adjuvant radiotherapy. The overall 5-year survival
was33%,butonly20%ofthepatientswerediseasefree.Once
again, size of the tumor was an important predictor, patients
with lesion >10cm died of disease, compared with 67% with
al e s i o n<10cm. Four of six patients treated with wide local
excision for lesions <10cm survived 5years [13]. Although
laryngealangiosarcomaisextremelyrareandasof2003there
are 14documented cases in the literature [2], there may be
more speciﬁc diagnostic and therapeutic challenges associ-
ated with documented radiation angiosarcoma as compared
to cases that were not previously irradiated (Table 1). For
example, Muira et al. [2] report in 2003 the second case of
radiation-induced laryngeal angiosarcoma in a patient who
had previously been treated with radiation for tuberculous
lymphadenopathy at age 28 and chemo and radiation for
supraglottic squamous cell carcinoma at age 60. The patient
subsequently had a total laryngectomy for what was thought
to be recurrent SCCA based on the biopsy results. Final
pathology returned positive for angiosarcoma. This patient
also recurred with skin, breast, and muscle metastasis after
one year and 10months each of which was treated with
excision and chemotherapy. As of the date of the report
the patient was stable for 3years and six months after total
laryngectomy [2].6 Case Reports in Otolaryngology
Thomas [1] reports a case of a 61-year-old male who
underwent radiation for SCCA of the vocal folds treated with
70Gy. Eleven years later the patient developed hoarseness,
exam revealed a laryngeal mass which biopsies demonstrated
dysplasia with dilation of capillaries and lymphatics without
inﬁltrative growth. The patient underwent laryngopharyn-
gectomy, and ﬁnal pathology was angiosarcoma. The patient
had local recurrence and expired after 13months. Thomas
and Muira both underscore the both the diagnostic dilemma
and the multifocality of disease than can occur in the subset
of previously irradiated angiosarcomas of the larynx. Many
of the rare published reports of angiosarcoma did not ﬁt
diagnostic criteria with immunostaining, and there may be a
possibility for over diagnosis [2]. Of note, a prior literature
review of cutaneous angiosarcoma of the head and neck,
three of the ten cases initially diagnosed as angiosarcoma
werechangedtoeosinophilicgranuloma,SCCA,andheman-
gioendothelioma underscoring the diagnostic diﬃculty [12].
In addition to the pathologic diagnostic dilemma asso-
ciated with this condition, cases must also fulﬁll criteria for
radiation-induced sarcoma. Although several authors report
prior radiation in association with cases of angiosarcoma of
the larynx (Table 2), speciﬁc criteria must be met todiagnose
a radiation-induced sarcoma. Our current case meets all of
these criteria.
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